MyoAAV-4A Serotype
Fourth myoAAV variant from M-CREATE selection, completing the muscle-targeted AAV toolkit with distinct properties.
| Tropism | Skeletal muscle, cardiac muscle, cross-species validated |
|---|
Characteristics
Additional M-CREATE isolate with unique characteristics. Balanced skeletal and cardiac muscle transduction. Cross-species validation. Alternative pharmacology to other myoAAV variants.
Applications
Multi-muscle tissue gene therapy. Systemic muscular dystrophy treatments. Translational applications.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Tabebordbar et al. (2021). Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell — Tabebordbar 2021 MyoAAV
